Lung Cancer Awareness Month 2024

Denise, a 14-year stage IV lung cancer survivor, was given just 10-15 months. But she chose to live life fully, educate herself, and support research that drives progress. Thanks to clinical trials, she's here today to share her story and encourage others to join the IASLC STARS program and make a difference in lung cancer research. 

Barry’s journey with cancer and his family's history have inspired him to give back and uplift others. Barry says, “If you want to make a difference with your voice, don’t sit back and wait for someone to tap you on the shoulder. Reach out to organizations—they’re looking for people who have heart and are committed to making a difference!”

Bev is a patient with Stage 4 lung cancer, is a passionate Patient Resource Advocate (PRA) who is using her voice to make a difference. Bev's dedication to speaking up for all patients reminds us that we are stronger together in this fight. Her story is a powerful reminder of the importance of advocacy, hope, and community.

"Research Matters!" says Dave Bjork, urging others to join the #IASLC STARS Scholar program. As a lung cancer survivor, Dave highlights the benefits of becoming a STARS Scholar—gaining mentorship, building camaraderie, and ensuring the patient voice shapes drug development. Ready to make a difference? Join the movement!

As an immunology scientist and 7-year ALK-positive lung cancer survivor, Emily Venanzi got involved in advocacy to push lung cancer research forward. Her journey shows the power of combining science with personal experience. Ready to make a difference? Get involved today!

Jim Pantelas, a 19-year lung cancer survivor and former smoker, shares his inspiring journey and emphasizes the importance of advocacy in the fight against lung cancer. “Everyone’s voice is needed in this fight,” Jim reminds us. Whether you're a survivor, caregiver, healthcare professional, or advocate, your story can make a difference! Join us durign #LCAM24 in amplifying diverse voices and experiences. Together, we can break the stigma, foster understanding, and create a stronger, more compassionate community.

Anita McGrath, a non-small cell lung cancer patient from Brisbane, Australia, is committed to making a difference. Through her work with the STARS program, she advocates for better access to targeted therapies across Australia and shares her journey to empower others. Thank you, Anita, for being a voice for the lung cancer community!

Her advocacy is personal—her mother was diagnosed with Stage 4 Adenocarcinoma Lung Cancer with an EGFR mutation. Using social media to share their journey, she connected with others and found strength in community. Watch the video to learn more about her impactful work in lung cancer advocacy.

Matthew Koebbe’s advocacy journey began when he experienced side effects from his lung cancer treatments. This sparked a deeper dive into research and engagement with the STARS PRA program. Through his work, he’s helping amplify patient voices and improve quality of life in lung cancer care.

Angeline Low is not just a survivor—she’s a powerful voice for lung cancer awareness and advocacy! In her heartfelt message, she proclaims, “I’m alive! Thank you.” Angeline's journey highlights the resilience and strength of those affected by lung cancer, reminding us all of the importance of support, awareness, and community. Watch her inspiring story and join us in amplifying the voices of lung cancer survivors!

In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion about the role exercise plays in complementing cancer treatment and how clinicians can work with patients to add regular exercise to their daily regimen.

In this episode of Lung Cancer Considered, Dr. Aakash Desai moderates a discussion in Hindi on the management of non-small cell lung cancer and small cell lung cancer in the Indian context. The group discusses advances in immunotherapy in resectable NSCLC and other new treatments on the horizon.

In this virtual tumor board episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the management of a patient with metastatic squamous NSCLC. Listen to the episode to learn how the guests would approach this case.

Lung cancer breakthroughs, practice updates, and key meetings made 2024 one of the most consequential years in recent memory for lung cancer researchers and clinicians. Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephen Liu reviewed important meetings and significant clinical trials from 2024 in this special episode.